MILLENDO THERAPEUTICS
Edit

MILLENDO THERAPEUTICS

http://www.millendo.com/
Tags:BioTechDevelopmentHealthTechMedTechProduct
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing’s Syndrome (CS).
Location: United States, Michigan, Ann Arbor
Member count: 11-50
Total raised: $92M
Founded date: 2012

Investors 4

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
09.08.2018-$30M-finsmes.co...
05.01.2016Series B$62M-5amventure...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
27.03.2019Roundup: Q...Share Share on Facebook Share ...-Sarah Schm...xconomy.co...
09.08.2018OvaScience...OvaScienceSM (Nasdaq:OVAS) and...USA-finsmes.co...
12.01.2018How female...We are excited to bring Transf...-Alida Mira...venturebea...
12.01.2018How female...Women remain underrepresented ...--hpa.vc/how...
12.01.2018How female...Women remain underrepresented ...-Alida Mira...venturebea...
20.12.2017Af­ter ax­...Mil­len­do Ther­a­peu­tics has...-Brittany M...endpts.com...
20.05.2017Why I love...We are excited to bring Transf...-Ted Serbin...venturebea...
20.05.2017Why I love...People often ask me, “Why did ...-Ted Serbin...venturebea...
13.09.2016Millendo L...Share Share on Facebook Share ...-Sarah Schm...xconomy.co...
05.01.2016MILLENDO L...---5amventure...
Show more